Check Out What Whales Are Doing With AMGN
Portfolio Pulse from Benzinga Insights
A large investor has taken a bearish stance on Amgen (NASDAQ:AMGN), with 60% of big-money traders also showing bearish sentiment. The whale's activity was noticed through publicly available options history. The whale and other big-money traders have been targeting a price range from $200.0 to $300.0 for Amgen over the last 3 months. Barclays, Oppenheimer, and Credit Suisse have maintained their ratings on Amgen, with price targets of $210, $280, and $200 respectively.
July 27, 2023 | 7:31 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A large investor has taken a bearish stance on Amgen, indicating potential downward pressure on the stock. Analysts' price targets range from $200 to $280.
The bearish stance taken by a large investor, along with the bearish sentiment of 60% of big-money traders, could put downward pressure on Amgen's stock price. However, the price targets set by Barclays, Oppenheimer, and Credit Suisse suggest that the stock could still have upside potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100